DK1228708T4 - Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk - Google Patents

Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk

Info

Publication number
DK1228708T4
DK1228708T4 DK02000982T DK02000982T DK1228708T4 DK 1228708 T4 DK1228708 T4 DK 1228708T4 DK 02000982 T DK02000982 T DK 02000982T DK 02000982 T DK02000982 T DK 02000982T DK 1228708 T4 DK1228708 T4 DK 1228708T4
Authority
DK
Denmark
Prior art keywords
milk
blood pressure
high blood
protein fraction
basic protein
Prior art date
Application number
DK02000982T
Other languages
English (en)
Other versions
DK1228708T3 (da
Inventor
Toba Yasuhiro
Takada Yukihiro
Morita Yoshikazu
Abe Takumi
Kawakami Hiroshi
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26607795&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1228708(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP2001008189A external-priority patent/JP4034516B2/ja
Priority claimed from JP2001008190A external-priority patent/JP4028177B2/ja
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of DK1228708T3 publication Critical patent/DK1228708T3/da
Application granted granted Critical
Publication of DK1228708T4 publication Critical patent/DK1228708T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/268—Hydrolysates from proteins
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/261—Animal proteins
    • A21D2/263—Animal proteins from dairy products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK02000982T 2001-01-16 2002-01-16 Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk DK1228708T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001008189A JP4034516B2 (ja) 2001-01-16 2001-01-16 脂質代謝改善剤
JP2001008190A JP4028177B2 (ja) 2001-01-16 2001-01-16 血圧降下剤

Publications (2)

Publication Number Publication Date
DK1228708T3 DK1228708T3 (da) 2004-07-05
DK1228708T4 true DK1228708T4 (da) 2008-01-07

Family

ID=26607795

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02000982T DK1228708T4 (da) 2001-01-16 2002-01-16 Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk

Country Status (7)

Country Link
US (2) US20030040475A1 (da)
EP (1) EP1228708B2 (da)
AT (1) ATE261669T1 (da)
DE (1) DE60200256T3 (da)
DK (1) DK1228708T4 (da)
ES (1) ES2215940T5 (da)
PT (1) PT1228708E (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3028411B2 (ja) 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
DK1142481T4 (da) * 1999-01-11 2009-12-21 Calpis Co Ltd Fremgangsmåde til fremstilling af fermenteret mælk indeholdende et peptid, der inhiberer et angiotensinomdannende enzym og fremgangsmåde til fremstilling af mælkeserum
JP4633876B2 (ja) 1999-11-11 2011-02-16 カルピス株式会社 トリペプチドの製造方法
JP2002193817A (ja) * 2000-12-28 2002-07-10 Calpis Co Ltd 整腸剤
JP3668241B2 (ja) * 2001-12-28 2005-07-06 株式会社Ｎｒｌファーマ 脂質代謝改善用組成物
WO2005074968A2 (en) * 2004-02-10 2005-08-18 Universiteit Maastricht Medical use of basic peptides
EP1685764A1 (en) 2005-01-27 2006-08-02 Globus Egg Sciences B.V. Anti-hypertensive functional food products
TW200605902A (en) * 2004-08-05 2006-02-16 Maxluck Biotechnology Corp Composition for lowering blood lipid
EP1930017B1 (en) * 2005-09-29 2012-05-23 Maruha Nichiro Seafoods, Inc. Composition effective for prevention and treatment of adult disease
CN101646448B (zh) * 2007-03-12 2017-02-08 雪印惠乳业株式会社 生长激素分泌促进剂
EP2195030B1 (en) * 2007-09-14 2014-05-07 CamNutra Limited Isoflavone formulation
FI122252B (fi) * 2008-01-04 2011-10-31 Valio Oy Koostumus maksa-aineenvaihdunnan parantamiseksi ja diagnostinen menetelmä
EP2318021A4 (en) * 2008-06-26 2012-10-31 Healthlinx Ltd PROTOCOLS FOR THE TREATMENT AND PREVENTION OF FAT SUPPORT AND COMPLICATIONS THEREOF
MX337716B (es) * 2010-03-10 2016-03-16 Kaneka Corp Preparacion que contiene bacteria de acido lactico.
WO2012102100A1 (ja) 2011-01-26 2012-08-02 雪印メグミルク株式会社 感覚改善剤
IL282198B2 (en) 2011-09-11 2025-11-01 Minovia Therapeutics Ltd Compositions of functional mitochondria and uses thereof
JP6309202B2 (ja) * 2013-03-28 2018-04-11 雪印メグミルク株式会社 タンパク質組成物およびその製造方法
JP6395350B2 (ja) * 2013-03-28 2018-09-26 雪印メグミルク株式会社 筋萎縮防止剤
JP7586811B2 (ja) 2018-07-22 2024-11-19 ミノヴィア セラピューティクス リミテッド 腎臓疾患のミトコンドリア増強療法
WO2020021535A1 (en) 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of ocular diseases
EP3823646A4 (en) 2018-07-22 2022-06-08 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of brain diseases
EP3823644A4 (en) 2018-07-22 2022-06-08 Minovia Therapeutics Ltd. MITOCHONDRIAL AUGMENTATION THERAPY OF PANCREATIC DISEASES
AU2019311859B2 (en) 2018-07-22 2025-12-18 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy for primary mitochondrial diseases
US11951135B2 (en) 2018-07-22 2024-04-09 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of muscle diseases
BR112022019609A2 (pt) 2020-03-31 2022-11-29 Minovia Therapeutics Ltd Células geneticamente modificadas enriquecidas com mitocôndrias e usos das mesmas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE458818B (sv) † 1987-11-27 1989-05-16 Svenska Mejeriernas Riksforeni Foerfarande foer utvinning av rena fraktioner av laktoperoxidas och laktoferrin ur mjoelkserum
AUPN271295A0 (en) * 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
DK0545946T3 (da) * 1990-07-13 2005-05-23 Gropep Ltd Vækstfremmende middel
JP2944008B2 (ja) * 1990-09-20 1999-08-30 森永乳業株式会社 非経口脂質代謝改善剤
JP2974604B2 (ja) † 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
JP4082782B2 (ja) * 1998-04-30 2008-04-30 雪印乳業株式会社 歯周病予防及び改善剤
US6649590B2 (en) * 2000-06-09 2003-11-18 Snow Brand Milk Products Co., Ltd. Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof

Also Published As

Publication number Publication date
ES2215940T3 (es) 2004-10-16
DK1228708T3 (da) 2004-07-05
EP1228708B1 (en) 2004-03-17
US20030040475A1 (en) 2003-02-27
ATE261669T1 (de) 2004-04-15
EP1228708B2 (en) 2007-08-22
EP1228708A2 (en) 2002-08-07
PT1228708E (pt) 2004-05-31
DE60200256T3 (de) 2008-04-03
DE60200256T2 (de) 2005-03-03
EP1228708A3 (en) 2002-08-14
DE60200256D1 (de) 2004-04-22
ES2215940T5 (es) 2008-03-16
US20040167078A1 (en) 2004-08-26
US6929806B2 (en) 2005-08-16

Similar Documents

Publication Publication Date Title
DK1228708T3 (da) Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk
CY1110547T1 (el) Συμπυκνωμενα πρωτεϊνικα σκευασματα μειωμενου ιξωδους
UY27940A1 (es) Formulacion de anticuerpos humanos para el tratamiento de trastornos asociados con tnf-a
DE602005026031D1 (de) Kristalline formen von (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenolhydrochlorid zur verwendung als aktivstoff in pharmazeutischen zubereitungen
ATE374016T1 (de) Tablette mit hohem wirkstoffgehalt
DK1492761T3 (da) Aminosyrer med affinitet til alpha-2-delta-proteinet
NO20062508L (no) Administrering av levodopa og karbidopa
WO2004091497A3 (en) Methods and compositions for increasing the anaerobic working capacity in tissues
ECSP088962A (es) Nuevos herbicidas
ATE488233T1 (de) Verminderung der nebenwirkungen bei der oxybutynin-therapie
EP2186824A3 (en) Chronic treatment regimen using glucagon-like insulinotropic peptides
WO2003016335A3 (en) Irreversible cysteine protease inhibitors of legumain
WO2004006756A3 (en) THERAPIES FOR RENAL FAILURE USING INTERFERON-β
EA200800337A1 (ru) Композиция и способ введения офтальмологически активных средств
DK1185253T3 (da) Oralt præparat til indgivelse af en fast kombination af tramadol og diclofenac
WO2006041641A3 (en) Therapeutic agents with decreased toxicity
EP1466602A4 (en) ORGAN FIBROSIS INHIBITORS
WO2006077427A3 (en) Antiviral drug combinations
IS8308A (is) Amínósýrur með sækni fyrir a2o prótíninu
NO993407L (no) Fremstilling av proteinpreparater med nedsatt aggregatinnhold
NO20034524L (no) 5-leddete heterocykler, fremstilling og anvendelse derav som MAO inhibitorer og lipidperoksidasjonsinhibitorer, fremstilling derav oganvendelse derav sommedikamenter
DK1418905T3 (da) Terapeutisk middel til depletering af en uönsket proteinpopulation fra plasma
DE50204475D1 (de) Präparationen von vitamin e in kombination mit afamin
EA200701072A1 (ru) Препараты бензотиазола и их применение
DK1275638T3 (da) Kombinationspræparat til behandling af immunologiske sygdomme